Serial 79366910
Live / Registered — Registered (as of 22 Oct 2024)
What this means for you
Registered since 22 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79366910
- Registration number
- 7539792
- Mark type
- Design / logo
- Filed
- 03 Dec 2022
- Published for opposition
- 06 Aug 2024
- Registered
- 22 Oct 2024
- Attorney of record
- Katrin Lewertoff
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science; biological preparations for use in industry and science
- Class 003 — Cosmetics and cleaning preparations: Non-medical cosmetics
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medical preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; veterinary preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; pharmaceutical preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicinal healthcare preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicinal preparations and substances, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicines for human purposes, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicines for veterinary purposes, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; nutritional supplements for human purposes; nutritional supplements for veterinary use; dietetic foods adapted for medical purposes
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely, scientific research in the medical and pharmaceutical fields and design relating thereto, namely, design and testing of new products for others; industrial analysis and research services in the medical and pharmaceutical fields; industrial design; research and development of new products for others; medical research services; technical research services in the medical and pharmaceutical fields; quality control for others; chemical analysis; medical and scientific research, namely, conducting clinical trials for others; chemical laboratories; technological research in the medical and pharmaceutical fields; scientific research; all aforementioned services not in relation to surface finishing and material analysis
Owner
- Helaxa GmbH & Co. KG, 20097 Hamburg, DE
- Helaxa GmbH & Co. KG, 20097 Hamburg, DE
- Helaxa GmbH & Co. KG, 20097 Hamburg, DE
Prosecution history
- 14 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Apr 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Mar 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Mar 2025 — FINAL DISPOSITION PROCESSED
- 22 Jan 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Sept 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 04 Sept 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 04 Sept 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED